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Ultrasonic Perfluorohexane-Loaded
Monocyte Imaging
Toward a Minimally Invasive Technique for Selective Detection
of Liver Inflammation in Fatty Liver Disease
Koen D. Reesink, PhD, Tim Hendrikx, PhD , Patrick J. van Gorp, BASc, Arnold P. Hoeks, PhD,
Ronit Shiri-Sverdlov, PhD
Objectives—To investigate the utility of ultrasonic (US) perfluorohexane (PFH)-
loaded monocyte imaging for detection of liver inflammation in fatty liver disease.
Methods—C57Bl6 mice were injected intraperitoneally with tumor necrosis factor
a and assessed by US PFH-loaded monocyte imaging 3 hours later. Echogenic
monocytes were injected intravenously, leading to a transient increase in liver tissue
intensity on a US perfusion scan. The contrast wash-out time constant was hypothe-
sized to reflect the degree of inflammation. Next, we evaluated US PFH-loaded
monocyte imaging in Ldlr2/2 mice fed a 1-week high-fat/high-cholesterol diet as
model for early developing nonalcoholic steatohepatitis. Adjunct analyses included
tissue markers of liver inflammation.
Results—Tumor necrosis factor a–injected mice showed a reduced wash-out
time constant (mean 6 SEM, 0.013 6 0.003; n 5 8) compared to controls
(0.054 6 0.009; n 5 7; P 5 .0006), indicative of increased inflammatory adhe-
sion molecule expression on the endothelium. The Ldlr2/2 mice fed the high-
fat/high-cholesterol diet showed liver inflammation, as reflected by increased (3-
to 4-fold) infiltration of inflammatory cells and increased (3- to 4-fold) gene
expression of tumor necrosis factor a, integrin aM, intracellular adhesion mole-
cule, and vascular cell adhesion molecule. However, in these mice, no difference
was detected in the wash-out time constant as assessed by US PFH-loaded
monocyte imaging (high-fat/high-cholesterol, 0.050 6 0.017; n 5 5; chow,
0.048 6 0.006; n 5 6; P 5 .91).
Conclusions—Our results indicate that US PFH-loaded monocyte imaging is able
to detect vascularly expressed inflammatory adhesion molecules in the mouse liver
on direct endothelial stimulation. However, in our mouse model of early developing
nonalcoholic steatohepatitis, we did not detect inflammation by this method, which
may suggest that the time-dependent relationship between parenchymal and endo-
thelial inflammation remains a fundamental issue to be addressed.
Key Words—endothelium; animal studies; basic science; fatty liver;
gastrointestinal; inflammation; macrophage; monocyte; nonalcoholic
steatohepatitis; noninvasive; perfusion; therapeutic; ultrasound contrast
N onalcoholic fatty liver disease is a chronic liver disorder rang-ing from benign hepatic lipid accumulation (steatosis) tosteatosis combined with inflammation, the latter termed
nonalcoholic steatohepatitis (NASH). Estimates in United States are
that 17% to 33% of all adults have nonalcoholic fatty liver disease,
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ORIGINAL RESEARCH
whereas 5% to 17% have NASH.1–3 Although steatosis
alone is considered a relatively benign and reversible
condition, the development of inflammation represents
a key step in liver pathogenesis. Liver inflammation,
when untreated, will set the stage for liver fibrosis, cir-
rhosis, and eventually liver failure. As NASH is mostly
asymptomatic, it is necessary to be able to detect hepatic
inflammation at an early stage. At present, liver biopsy is
the clinical standard for assessing (the progression of)
inflammation in fatty livers. However, the procedure has
several limitations, including discomfort, longer hospital-
ization, and risk of serious complications due to its inva-
siveness.4,5 Moreover, diagnosing NASH by biopsy can
be associated with sampling errors. In fact, the negative
predictive value of a single biopsy for the diagnosis of
NASH is estimated at 74%.6 Finally, an inadequate-
length or fragmented biopsy specimen can make the cor-
rect diagnosis even more challenging.7,8 Thus, it is
extremely important to develop less-invasive techniques
for the diagnosis of hepatic inflammation and to discrim-
inate simple steatosis from NASH.7,9
Several imaging modalities have been advocated as
less-invasive or noninvasive diagnostic tests for simple
steatosis, including ultrasonic (US) imaging, computed
tomography, magnetic resonance imaging, and recently,
also magnetic resonance spectroscopy.9–12 Unfortu-
nately, so far these existing imaging techniques have
insufficient sensitivity and specificity for distinguishing
NASH from noninflammatory fatty liver disease.9 Ultra-
sonic imaging is extensively used clinically because it is
safe, versatile, and noninvasive and enables global assess-
ment of organ tissue.9,13 Ultrasonic tissue elastography
and derivatives are now routinely considered to support
diagnosis of (advanced) liver fibrosis but do not provide
an independent assessment of the inflammation grade
present in the liver.13
In US contrast imaging, a contrast agent (typically
microbubbles)14,15 is infused into the circulation to
assess tissue perfusion. Previously, we have shown that
macrophages can be made echogenic by perfluorohex-
ane (PFH) loading while retaining their function as bio-
logical sensors for inflammation.16,17 Perfluorohexane is
a nontoxic, biodegradable, and fluid (ie, nongaseous) US
contrast agent that is readily ingested by monocytes/
macrophages on incubation.16,18 We found that PFH-
loaded macrophages were detectable in vivo on US
imaging in arterial blood after intravenous injection (ie,
they circulate) and specifically interact (roll and attach)
with activated endothelium in mouse carotid arteries.17
On the basis of these functional findings and in view of
the nontoxic nature of PFH, we chose to investigate
the utility of PFH-loaded cells for detection of liver
inflammation.
In the present study, we hypothesized that the pres-
ence and degree of liver inflammation would be reflected
in the number and activity of proinflammatory adhesion
molecules in the liver vasculature/endothelium. In such
a case, a passing bolus of PFH-loaded monocytes will
have a higher adhesion affinity, which may delay its
wash-out as recorded by US imaging (Figure 1).
Our methodological approach was to inject an intra-
venous bolus of contrast cells during a continuous liver
echo recording and to quantify the wash-out time con-
stant as a measure of the inflammation degree (Figure
1). To evaluate our US PFH-loaded monocyte imaging
approach, we performed 2 experiments. In the first, we
injected C57Bl/6 mice intraperitoneally with tumor
necrosis factor a (TNF-a) to simulate vascular endothe-
lial activation.19 In the second experiment, Ldlr2/2 mice
were fed a high-fat/high-cholesterol diet for 1 week to
model NASH development.20 In both experiments we
included control groups and obtained US PFH-loaded
monocyte imaging recordings. In this analysis, we
focused on the proof of principle for the US PFH-
loaded monocyte imaging method and included adjunct
immunohistochemical findings to discuss its (potential)
validity and applicability.
Materials and Methods
Experimental Animal Models
All experiments were performed according to Dutch reg-
ulations and approved by the Ethical Committee for
Animal Welfare of Maastricht University. Mice (20–
30 g) were housed under standard conditions and given
free access to food and water. For the first experiment,
TNF-a (15 lg/kg) or phosphate-buffered saline (PBS;
control) was injected intraperitoneally in 10- and 12-
week-old male C57BL/6 mice 3 hours before US PFH-
loaded monocyte imaging measurements (TNF-a,
n 5 11; PBS, n 5 11), based on the findings of Fox-
Robichaud and Kubes.19 For the second experiment, 10-
week-old Ldlr2/2mice (C57BL/6 background strain)
were given either chow or a high-fat/high-cholesterol
diet for 1 week to induce hepatic tissue inflammation
(chow, n 5 10; high-fat/high-cholesterol, n 5 10). The
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high-fat/high-cholesterol diet consisted of the chow diet
supplemented with 20% milk butter and 1% cholesterol.
Preparation of the PFH Emulsion
For preparation of the PFH emulsion, 68% lecithin
(Avanti Polar Lipids, Alabaster, AL) and 2% 1,2-bis(di-
phenylphosphino)ethane (Avanti Polar Lipids) were
added to 30% cholesterol (Sigma Aldrich, Steinheim,
Germany) and mixed well.16 Then evaporation at 608C
under nitrogen was performed to prepare a dry lipid
mixture, which was followed by the addition of 856 lL
of Milli-Q (Millipore, Billerica, MA). This mixture was
hydrated for 1 hour and vortexed regularly to dissolve
the surfactant. Once the sample was fully hydrated,
144 lL of PFH (40%, C6F14; Sigma Aldrich) was
added to the lipid surfactant sample. The PFH-
surfactant mixture was emulsified by loading it into a
gas-tight syringe fitted to one end of a mini-extruder
(Avanti Polar Lipids). By gently pushing the plunger of
the filled syringe, the lipid solution was completely trans-
ferred into the opposite syringe. This step was reversed
and repeated at least 25 times to have a homogeneous
lipid solution.16 The emulsified mixture was centrifuged
for 30 minutes at 2000g, and the PFH emulsion (pellet)
was then dissolved in 2 mL of PBS, ready to be used for
loading bone marrow–derived macrophages. As previ-
ously established and described, PFH is and remains a
fluid under the in vitro and in vivo conditions we consid-
ered (http://www.rsc.org/learn-chemistry/wiki/Sub-
stance:Perfluorohexane). Its boiling temperature is
Figure 1. Background, approach, and hypothesis of US PFH-loaded monocyte imaging for assessment of liver inflammation.Top left, When, dur-
ing liver (parenchymal) inflammation, the endothelial cells increasingly express adhesion molecules, monocytes/leukocytes will tend to roll and
adhere more on the endothelial surface, facing the shearing forces of the bloodstream that naturally wash out these cells from the liver vasculature.
Right, As scavengers, monocytes naturally ingest foreign material, such as PFH emulsion droplets, which after incubation will yield monocytes
containing conglomerates of PFH droplets, effectively rendering the cells echogenic. On intravenous bolus injection, the echogenic cells will be
diluted in the native blood and transported by the bloodstream toward the liver, where the tissue will be transiently highlighted by the echo-
contrasted cells. Bottom left, With the assumed increased adhesion of the PFH-loaded monocytes with liver inflammation, the time-intensity
curves of the US recording are hypothesized to show a reduced wash-out rate: ie, a reduced wash-out time constant.
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568C, and the mechanical index of the US B-mode imag-
ing we used was far below levels that could lead to evap-
oration or cavitation.16,17 The absence of evaporation/
cavitation is corroborated by our experience, in that in
our hands, we have not been able to destroy PFH drop-
lets (monitored by a Vevo 2100 B-mode US system;
FUJIFILM VisualSonics, Toronto, Ontario, Canada)
deposited on agar (submerged in PBS)16 using the Vevo
SoniGene sonoporation tool at maximum power deliv-
ery (2 W/cm2 continuous for 30 seconds; our unpub-
lished data). The PFH echogenicity stems from the
large difference between its acoustic impedance (0.875
MRayl) and that of blood and cells, for example (1.5
MRayl).17
Bone Marrow–Derived Macrophages
Bone marrow–derived macrophages were isolated from
the tibias and femurs of C57BL/6 donor mice. Cells
were cultured in RPMI-1640 (GIBCO Invitrogen,
Breda, the Netherlands) with 10% heat-inactivated fetal
calf serum (Bodinco BV, Alkmaar, the Netherlands),
penicillin (100 U/mL), streptomycin (100 lg/mL), and
L-glutamine (2 mM; all from GIBCO Invitrogen) sup-
plemented with 20% L929-conditioned medium for 8 to
9 days to generate bone marrow–derived macrophages.
After attachment, the macrophages were seeded at
2 3 106 cells per well in 6-well plates for incubation for
16 hours with 4% PFH emulsion.16 Loaded cells were
visually inspected to verify uptake and the integrity of
the PFH emulsions in the cells we established previ-
ously.16,17 Then cells were washed and collected for fur-
ther use. The PFH-loaded cells effectively act as
containers of conglomerates (in vitro cell size >10 lm)17
of the approximately 300-nm PFH emulsions,21 dose-
dependently enhancing the echogenicity of the loaded
cells up to 18 dB, as illustrated previously by light micros-
copy, flow cytometry, and in vitro US imaging (using a
7.5-MHz linear array).16 The properties and echogenic
potential of the PFH-loaded cells given as an intravenous
bolus have been detailed previously.17
Ultrasonic Recording Setup
We used the Vevo 2100 high-resolution US scanner
with an MS-400 linear array transducer (bandwidth, 18–
38 MHz; operated at 30 MHz) to record B-mode cine
loops. Images were acquired in a single focus zone, with
the focus depth in the middle of the liver section consid-
ered. Depth-dependent gain was manually adjusted to
avoid saturation, which primarily affected the high
intensity of the skin layers and border of the liver cross
section. This setting remained fixed between experi-
ments while the imaging depth was kept constant. We
acquired images triggered by an electrocardiographic
(ECG) R wave detected halfway through the expiration
period, minimizing movement artifacts while ensuring
an adequate frame rate of 1 per respiratory cycle (Vevo
2100, Physio settings, respiratory gating and ECG gat-
ing; minimal respiratory window width, positioned at
the middle, flattest portion of the respiratory signal;
ECG gate T1 on and set to 0 milliseconds). Conse-
quently, the time for the time-intensity curves was
expressed in trigger cycles (each corresponding to a
respiratory cycle), and the wash-out time constant as 1
per cycle (further details below).
Experimental Protocol
Mice were anesthetized 30 minutes after premedication
with buprenorphine (0.03 mg/kg) by inhalation of 3.0%
to 3.5% isoflurane through a Univentor 410 vaporizer
(UNO, Zevenaar, the Netherlands). Subsequently, the
chest and belly were shaved and dehaired (VEET;
Reckit Benckiser, Hull, England) with the animal’s nose
and mouth positioned in a breathing mask, maintaining
anesthesia by inhaled isoflurane at 1.8% to 2.5%. Then
the right jugular vein was exposed to introduce (1 cm
toward the right atrium) a venous cannula (P10, Portex;
Smiths Medical International, Kent, England) with an
approximately 20-cm external length terminated by a 1-
mL syringe with 0.9% saline via a truncated 30-gauge
needle for flushing. Subsequently, the anesthetized and
cannulated mouse was transferred to the Vevo 2100
scanning platform. The paws were carefully positioned
and fixated on electrodes for ECG and plethysmo-
graphic registration, ensuring good contact by applica-
tion of electrode gel. The rectal temperature was
monitored and manually regulated within 36.88C to
37.28C by an infrared lamp.
After positioning of the animal on the scanning plat-
form, the US transducer was placed just above the ani-
mal, with a 2- to 5-mm-thick US gel mass in between
(without air bubbles). Positioning was transverse and
initially roughly between lower ribs and bowels. The x-y
manipulator of the US setup was then used to adjust for
the maximum observed liver area with no or minimal
clutter from surrounding structures. Subsequently, dur-
ing a 2- to 5-minute period for stabilization of the respi-
ratory rate under inhaled isoflurane (40–60 cycles/min),
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the injectate syringe was prepared: ie, re-emulsification
of the cell emulsion in an Eppendorf container kept at
378C and uptake of 2–3 3 106 cells in 200 lL into a 1-
mL syringe with a truncated needle to fit the jugular
vein cannula. During and directly after connecting the
syringe to the cannula, settling of the cell emulsion was
prevented by rocking the syringe until injection com-
menced. The echo recording was started by freezing and
unfreezing the acquisition. Twenty trigger cycles (ie,
respiratory periods) were counted off to establish a base-
line, after which the injectate was injected smoothly over
50 to 60 trigger cycles (1 minute). The recording was
stopped after 400 trigger cycles and saved to the hard
disk on the Vevo 2100 system. Recordings were
exported as avi files to an external hard disk for offline
processing.
After the US measurements (as described above),
the animals were euthanized by cervical dislocation. Col-
lection of blood and tissue specimens, biochemical
determination of lipids in the liver, liver histologic analy-
sis, RNA isolation, complementary DNA synthesis, and
quantitative polymerase chain reaction were performed
as described previously.22
Ultrasonic Video Processing
The US video recordings were processed by a proprie-
tary algorithm written by written by APH (MATLAB
R2013b, The Mathworks, Natick, MA), according to the
following steps (in the order of execution): (1) Intensity
calibration was read from the calibration bar in the first
B-mode frame and applied in reverse to obtain linearly
scaled intensity values (ie, to decompress the normally
compressed grayscale range, which favors visual evalua-
tion but is unsuited to quantifying changes in intensity).
(2) Based on the first B-mode frame, a region of interest
(ROI) was selected to maximize the area of the liver sec-
tion considered while avoiding the borders of the liver
parenchyma. (3) Subsequently, spatial and temporal
smoothing was performed by a 3-dimensional uniform
running window with dimensions of (0.1 3 ROI
width) 3 (0.1 3 ROI depth) 3 9 sample points (ie, 9
respiratory cycles) in width, depth, and time, respec-
tively. (4) Based on the smoothed data, for a 3 3 3 grid,
time-intensity curves and their average were extracted
for an intermediate evaluation (see below). (5) A time
base marker was then manually set to define the baseline
(ie, preinjection) value. The baseline value was sub-
tracted from the time-intensity curve to isolate the
transient response from the steady-state background
intensity. The resultant time-intensity curves and proc-
essing parameters were saved to a hard disk.
At this point, we visually evaluated the US PFH-
loaded monocyte imaging recordings and excluded
recordings with no identifiable peak in the average time-
intensity curve (n 5 14) or with premature ending due
to hemodynamic instability of the mouse (n 5 5). Iden-
tification of the time-intensity curve peak is a necessary
requirement for determining the wash-out time constant
(next paragraph). The time-intensity curve peak was
assumed to occur within 100 trigger cycles from the start
of injection (illustrated in Figure 2, B and C). All mice
showed some cardiopulmonary response during of
immediately on injection: specifically, a transient
decrease in the respiratory rate. In 2 particular cases, this
response led to a disruption of the triggering, signal and
the recording stopped automatically (ie, by scanner
default). In those cases, another recording commenced
immediately and provided a sufficient wash-out period
to perform the analysis on. Final numbers of mice per
group included in this analysis of US PFH-loaded mono-
cyte imaging were 8 for TNF-a and 7 for PBS controls
and 5 for the high-fat/high-cholesterol diet and 6 for
chow controls.
For characterization of the wash-out, we assumed
the imaged liver blood pool to behave as a single com-
partment with a first-order wash-out response in time,
starting from the peak echo intensity level. Considering
that (1) our PFH-loaded cells are relatively inert (no
notable disintegration in vitro after 24 hours16; (2) sub-
stantial clearance/transgression of the cells out of the cir-
culation is unlikely to occur within the time frame
observed (5 minutes); and (3) the circulation is a sin-
gle compartment in which the bolus will dilute depend-
ing on circulatory flow,23 this first-order model appears
valid. Accordingly, we quantified the wash-out by a sim-
ple exponential decay time constant. To obtain an esti-
mate of the wash-out decay time constant that was
representative of the liver section imaged, the following
steps were taken: (1) The down slope of the average
time-intensity curve was manually defined by drag-and-
drop markers starting at the peak intensity and ending
close to 0. If after the first decay, a rise in intensity was
observed, the start of the rise was taken as the end of the
decay (Figure 2, B and C, block arrow 2). (2) Assuming
the first-order decay model, the decay characteristics
(amplitude and wash-out time constant) were obtained
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for the average time-intensity curve (online supplemen-
tal Figure S1, left panel). (3) For a grid, with an inter-
spacing of one-fourth of the corresponding smoothing
span in width and depth, time-intensity curves were eval-
uated (eg, for a smoothing span 20 3 12 wide 3 deep,
5 3 3 time-intensity curves were obtained). Only time-
intensity curves with an identifiable peak (same require-
ment as described above) and a wash-out time constant
within the range 0.5 to 2 of that of the average time-
intensity curve were accepted (online supplemental Fig-
ure S1, middle panel). (4) Finally, the histogram and
median of the wash-out time constants were displayed,
and the results were saved to the hard disk. The median
wash-out time constant was taken as representative of
the US PFH-loaded monocyte imaging measurement
considered (online supplemental Figure S1, right panel).
In a pilot data set, we evaluated the variability due
to ROI selection to assess the impact of artifactual
motion and consequent intensity changes due to edge
effects. We found a variability in the time constant of
about 30%, which compared favorably with the rate of
greater than 50% reported by Ignee et al,24 although
those investigators did not evaluate the wash-out time
constant as such. We have not conducted a laboratory
bench validation against a reference standard method for
the wash-out time constant. Consequently, the validity
of the time constant estimates necessarily relied on the
statistical power of multiple realizations over the ROI
and taking the median value.
Statistical Analysis
Data were analyzed with Prism version 4.0.3 software
(GraphPad Software, La Jolla, CA). Groups were com-
pared by an unpaired t test for comparing 2 groups. The
data are presented as mean 6 standard error of the
mean, unless noted otherwise. Differences between
experimental and respective control groups were consid-
ered significant at P< .05, P< .01, or P< .001.
Figure 2. A, In TNF-a-injected mice (n 5 8), the wash-out time constant (1 per cycle) was clearly decreased compared with PBS controls (n 5 7):
ie, the TNF-a group showed slower wash-out (***P 5.0006). Box plots show the median, interquartile range, and minimum-maximum range. B
and C, Time-intensity curves and manually defined wash-out ranges for 2 normal and 2 slowed wash-outs, respectively, with the time axis given in
(respiratory) cycles. The dots mark the start and end of the selected wash-out data for calculation of the time constants, assuming a first-order
decay curve (gray dotted lines). The numbers indicate the corresponding time constants (in 1/cycles). Block arrow 1 illustrates a nonmonotonous
rise in intensity during injection. Block arrow 2 illustrates selection of the end value of the decay in case a secondary rise in intensity follows.
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Results
Ultrasonic PMI Results 3 Hours After
Intraperitoneal TNF-a Injection
To test whether US PFH-loaded monocyte imaging
could be used to detect inflammation in the liver on
direct endothelial stimulation, C57Bl/6 mice were
injected intraperitoneally with TNF-a or PBS and
assessed by US PFH-loaded monocyte imaging 3 hours
later. As indicated in Figure 2A, wash-out was signifi-
cantly slower in the TNF-a mice with a directly acti-
vated endothelium compared to controls; wash-out
constants were 0.013 6 0.003 (n 5 8) and
0.054 6 0.009 (n 5 7), respectively (P 5 .0006). Figure
2, B and C, illustrates time-intensity curves and manually
defined wash-out ranges for 2 normal and 2 slowed
wash-outs, respectively.
Tumor Necrosis Factor a Injection Does Not Induce
a Hepatic Inflammatory Response
Mice were euthanized 3 hours after intraperitoneal injec-
tion of TNF-a, and livers were harvested for investiga-
tion of the development of hepatic inflammation. To do
so, liver sections were stained with antibodies against
infiltrating macrophages (Mac-1) and neutrophils (anti-
neutrophil antibody [NIMP]). Although a trend was
found toward increased infiltrating inflammatory cells
after TNF-a injection, no significant difference was
observed compared to control mice (n 5 10 for each
group; Figure 3, A and B). In addition, no difference in
hepatic gene expression of Tnf-a, integrin aM (Itgam),
intracellular adhesion molecule (Icam) and vascular cell
adhesion molecule (Vcam) was found between TNF-a-
injected and control mice (n 5 10 for each group; Fig-
ure 3C). These data indicate that 3 to 4 hours after
Figure 3. Parameters of hepatic inflammation in PBS- and TNF-a-injected mice. A, Liver sections were stained for infiltrating macrophages (Mac-
1) and neutrophils (NIMP), and the positive cells were counted. B, Representative images of Mac-1 staining (original magnification 3 200) in
PBS- and TNF-a-injected mice. C, Gene expression analysis of Tnf-a, Itgam, Icam, and Vcam. Gene expression data were set relative to PBS-
injected mice. Bar graph data are given as mean and SEM; for each group, n 5 10.
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intraperitoneal injection of TNF-a, the hepatic tissue
inflammatory response was (still) absent.
Ldlr2/2 Mice Develop Hepatic Steatosis and
Inflammation After 1 Week of a High-Fat/High-
Cholesterol Diet
After 1 week of the high-fat/high-cholesterol diet,
Ldlr2/2 mice developed hepatic steatosis, as indicated
by the increased hepatic levels of triglycerides, choles-
terol, and free fatty acids compared to Ldlr2/2 mice fed
the chow diet (n 5 10 for each group; online supple-
mental Figure S2A). In addition, CD68 staining (for
Kupffer cells) was performed, revealing a clear difference
between Ldlr2/2 mice fed the high-fat/high-cholesterol
diet and mice fed chow. As expected, in the Ldlr2/2
mice fed the high-fat/high-cholesterol diet, the Kupffer
cells were more swollen and foamy compared to Kupffer
cells in the chow-fed animals (online supplemental Fig-
ure S2B).
To investigate the development of hepatic inflam-
mation, liver sections were stained with antibodies
against several inflammatory markers, including macro-
phages (Mac-1) and neutrophils (NIMP). Higher num-
bers of infiltrating macrophages and neutrophils were
observed in the livers of the Ldlr2/2 mice fed the high-
fat/high-cholesterol diet compared to the Ldlr2/2 mice
fed the chow diet (n 5 10 for each group; Figure 4A),
as further illustrated by representative images from the
Mac-1 staining for infiltrating macrophages and neutro-
phils (Figure 4B). These findings were confirmed by
Figure 4. Parameters of hepatic inflammation in chow- and high-fat/high-cholesterol (HFC) diet-fed mice. A, Liver sections were stained for infil-
trating macrophages (Mac-1) and neutrophils (NIMP), and the positive cells were counted. B, Representative images of Mac-1 staining (original
magnification 3 200) after 1 week of the chow or high-fat/high-cholesterol diet in Ldlr–/– mice. C, Gene expression analysis of Tnf-a, Itgam, Icam,
and Vcam. Gene expression data were set relative to chow-fed mice. Bar graph data are given as mean and SEM. **P<.01; ***P<.001; for each
group, n 5 10.
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increased hepatic gene expression of Tnf-a, Itgam, Icam,
and Vcam in the Ldlr2/2 mice fed the high-fat/high-
cholesterol diet compared to the chow-fed Ldlr2/2
mice (Figure 4C). Taken together, these data indicate
that a 1-week high-fat/high-cholesterol diet results in
(detectable) liver tissue (ie, parenchymal) inflammation.
No Difference in Wash-out of PFH-Loaded
Monocytes in Ldlr2/2 Mice After 1 Week
of a High-Fat/High-Cholesterol Diet Compared
to Controls
Figure 5 shows that there was no significant difference
in wash-out time constants between the mice fed the
high-fat/high-cholesterol diet and the control mice fed
the chow diet. Wash-out time constants were 0.050 6
0.017 (n 5 5) and 0.048 6 0.006 (n 5 6), respectively
(P 5 .91).
Discussion
This study demonstrates proof of the principle for the
use of perfluorohexane-loaded monocytes as a contrast
agent and US B-mode cine recording as an imaging tool
for selective detection of liver inflammation. Direct
endothelial stimulation led to the hypothesized decrease
in the contrast wash-out time constant: ie, a slower
wash-out. Direct endothelial stimulation did not lead to
increased (parenchymal) inflammatory tissue markers.
In Ldlr2/2 mice fed the 1-week high-fat/high-choles-
terol diet (developing NASH), we did not detect a
slower wash-out, although immunohistologic markers
showed a clear inflammatory tissue phenotype. Below,
we will critically discuss our findings.
Our findings in the TNF-a-stimulated mice are in
line with the increased expression of vascular adhesion
molecules in the liver as reported by Fox-Robichaud and
Kubes19 and the increased adherence of native leuko-
cytes at the carotid artery endothelium as we recently
reported.17 The increased tendency of the PFH-loaded
macrophages to adhere leads to a prolonged residence
time (before a cell detaches again and is carried further
by the bloodstream) in the liver vasculature25 and hence
could well explain the hypothesized decreased wash-out
decay time constant we observed in the TNF-a-
stimulated mice.
Iijima et al15 obtained US time-intensity curves in
patients with NASH and simple steatosis, using a micro-
bubble contrast agent with no (inflammation-) specific
binding affinity with a focus on delayed enhancement of
liver tissue.15 Those investigators reported evidence of a
faster wash-out in a patient with NASH compared to a
patient with simple steatosis (cf Iijima et al,15 Figure 3).
Unfortunately, their analyses further focused on the
intensity level rather than wash-out timing and lacked
data on the correlation with the degree of inflammation
(also see Cobbold et al,9 “Discussion”). Moreover, their
use of a nonspecific contrast agent is at odds with the
pathophysiologic basis of our approach (Figure 1).2,19
In agreement with our previous observations,20
Ldlr2/2 mice develop steatosis and hepatic tissue
inflammation on short-term (ie, 1-week) high-fat/high-
cholesterol feeding, as reflected by our liver lipid analysis
and immunohistologic findings. In addition, the swollen
appearance of Kupffer cells with the high-fat/high-cho-
lesterol diet resembles foamy macrophages, as observed
during atherosclerosis, indicating the accumulation of
intracellular lipids in activated Kupffer cells, leading to
inflammatory signals. However, to what extent this
short-term high-fat/high-cholesterol diet leads to
(detectable) endothelial expression of adhesion mole-
cules is not yet known. In this setting for in vivo determi-
nation of hepatic inflammation, we did not find a
decreased wash-out time constant in high-fat/high-cho-
lesterol–fed mice compared to controls.
One explanation for this negative US PFH-loaded
monocyte imaging result in the high-fat/high-choles-
terol–fed mice pertains to the limited specificity of
our immunohistologic analysis. We determined gene
expression profiles in homogenates of liver tissue
excised and stored after the US PFH-loaded mono-
cyte imaging recordings. Given the estimation that
Figure 5. No difference in the US PFH wash-out time constant
between mice after 1 week of the high-fat/high-cholesterol (HFC) diet
(n 5 5) and chow diet (n 5 6); P 5.91. Box plots show the median,
interquartile range, and minimum-maximum range.
Reesink et al—Ultrasonic Perfluorohexane-Loaded Monocyte Imaging of Liver Inflammation
J Ultrasound Med 2018; 37:921–933 929
70% to 85% of the liver volume is taken up by hepato-
cytes,26 one may expect that the parenchymal contri-
bution to the expression of cell surface adhesion
molecules assessed in the homogenates may dominate
over that of the vascular endothelium. Consequently,
this factor likely limited us in assessing modulation of
endothelial adhesion molecule expression in the mice
fed the high-fat/high-cholesterol diet.
Another, more fundamental, issue may be that in
our high-fat/high-cholesterol–fed mice, the level of tis-
sue/parenchymal inflammation did not (yet) cause suf-
ficient endothelial adhesion molecule expression, hence
staying below the detection limit of our US PFH-
loaded monocyte imaging method. This factor does
prompt the question of what level of parenchymal
inflammation sets off increased expression of adhesion
molecules at the endothelial surface in the liver vascula-
ture (ie, around the Disse space). From atherosclerosis
research, it is known that inflammatory cells inside the
vessel wall release cytokines that trigger endothelial
expression of adhesion molecules, such as the ICAM
and VCAM integrins.27 In the liver, a similar chain of
inflammatory events is believed to occur,19,28 but differ-
ences in endothelial adhesion molecule expression pro-
files between locations (presinusoidal, sinusoidal, and
venular) are relevant to consider.19 An additional analy-
sis of the present data showed 2-fold expression of
Vcam in the mice fed the high-fat/high-cholesterol diet
directly compared to TNF-a-stimulated mice
(P 5 .003, 2-sample t test). However, leukocyte recruit-
ment in the liver vasculature is not solely governed by
VCAM to a4-integrin interaction.
29 A similar but tenta-
tive 2-fold increased expression of Tnf-a in our high-
fat/high-cholesterol–fed mice compared to our TNF-
a-stimulated mice (P 5 .096, 2-sample t test) may
have been less-directly linked to adhesion, given the
dominant parenchymal contribution of this cell surface
marker, as already discussed above. There were similar
expression levels of Itgam and Icam between the
groups, which do not support the interpretation of the
negative US PFH-loaded monocyte imaging finding in
the high-fat/high-cholesterol experiment. It should also
be noted that the (increased) size and deformability of
PFH-loaded cells (as described previously16,18 may
have an effect on wash-out dynamics. We have found
no evidence in the literature to substantiate differences
in vascular dimensions and perfusion between our
mouse models.24
Last, the time dependence of the relationship
between parenchymal and endothelial inflammation is
worth considering, given our findings. As we evaluated
US PFH-loaded monocyte imaging in Ldlr2/2 mice
after a 1-week high-fat/high-cholesterol diet (ie, with
NASH still developing), it might be that the endothelial
inflammation, when assuming it follows parenchymal
inflammation, had yet to become detectable. To the best
of our knowledge, this area, where the biophysics and
kinetics of cell migration and paracrine signaling play
major roles, has not been explored to a great extent, at
least not in the field of nonalcoholic fatty liver dis-
ease.2,19 Given the dynamic aspect of signaling and dis-
ease development, the timing of US PFH-loaded
monocyte imaging (and possible adjunct molecular
imaging) needs to be more carefully considered and
controlled in future studies.
For the characterization of the wash-out, we
assumed that the imaged liver blood pool was a single
compartment with a first-order wash-out response in
time, starting from the maximum echo intensity level. In
the time-intensity curves illustrated in Figure 2, second-
pass effects appeared to occur as a result of recirculation,
which was obviously present. However, considering the
potential factors influencing the time-intensity curve
away from the initial wash-out period, we did not, at this
point, consider using a more comprehensive perfusion-
circulation model suitable. Therefore, in our time-
intensity curve analysis, we explicitly assumed the initial
wash-out period to be a simple exponential decay. Our
time-intensity curves, as exemplified in Figure 2, suggest
that this approach is reasonable and practicable.
We obtained liver echo intensity frames triggered
on the respiratory plethysmogram. This method is a nec-
essary and effective way to reduce motion/intensity arti-
facts due to thorax and diaphragm movement.30 The
sampling rate appeared sufficient, whereas decay curves
spanned at least 40 trigger cycles (Figure 2, B and C).
Within each respiratory cycle, we obtained one frame
based on the ECG R wave and the gate set to the mini-
mal duration. However, the Vevo 2100 trigger unit uses
an ECG gate width as a fraction of the respiratory
period. Consequently, for animals with a relatively long
respiratory period with respect to the R-R interval, this
factor occasionally led to acquisition of 2 frames per res-
piration period. We could not easily correct for this error
because we did not have the ECG and respiratory signal
available in the avi format videos we analyzed. Because
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these errors were infrequent and did not consistently
occur, we consider their impact on the time constant
estimates limited.
We used manual injections to perform the US
PFH-loaded monocyte imaging measurements. An infu-
sion pump would clearly produce more even inflow over
the 50- to 60-cycle injection period. However, settling of
the cell emulsion was an issue: not rocking the syringe
led to fatal embolization of the lungs in preliminary
experiments using jugular vein access.17 Unsteady injec-
tion might have led to nonmonotonous rises in liver
intensity (illustrated by block arrow 1 in Figure 2, B and
C). Nevertheless, our manual injections of the 2 to
3 3 106 cells in 200 lL did lead to clearly identifiable
peak intensities in most mice, to serve as valid (ampli-
tude and time) references for the wash-out phase of
interest; the time-intensity curve course preceding the
identified peak is irrelevant for our approach (illustrated
by block arrow 2 in Figure 2, B and C).
We could not identify a peak intensity in 14 mice,
which deserves some consideration. It might be that in
these cases, liver perfusion was insufficient to lead to a
detectable time-intensity curve. Alternatively, loss of
PFH-loaded cells to adhesion outside the liver may
explain insufficient contrast enhancement in these ani-
mals. However, we did not find a notable difference in
the number of time-intensity curves with no identifiable
peak between the TNF-a and high-fat/high-cholesterol
experiments (n 5 6 and 8, respectively), although one
may expect a steal effect to be greater in TNF-a-treated
mice. The corresponding adhesion molecule expression
profiles of the mice with no identifiable peak were
around the average value of the respective whole group
(n 5 10 in each of the groups). For the immunohisto-
logic analyses, therefore, it is justified that we did use all
data available.
Although we optimized the injectate volume and
concentration in initial experiments, we still lost 5 US
PFH-loaded monocyte imaging outcomes because of
hemodynamic instability (see “Materials and Methods”).
As the dose was such that no obvious intensity increase
was noticeable by eye on the scanner (however measura-
ble), it might have been that conglomerates of cells did
reach the lungs and caused embolization there or farther
downstream.
In this study, we did not assess hemodynamic
differences between experimental groups (eg, by
contrast perfusion scanning with nonspecific affinity
to inflammatory adhesion molecules). Therefore, we
cannot exclude or discriminate a hemodynamic influ-
ence on the observed wash-out time constants but only
assume that in our models with acute endothelial stimu-
lation with TNF-a and developing NASH (Ldlr2/2
mice fed the 1-week high-fat/high-cholesterol diet),
these advanced effects, which may concur with advanced
fibrosis, are only minor.2 On visual inspection, we did
not notice a difference between the histogram shapes
of TNF-a-stimulated and of Ldlr–/– high-fat/high-
cholesterol–fed mice, which might have indicated a dif-
ference in wash-out kinetics.
Another important limitation was that we did not
assess in vivo endothelial adhesion molecule expression
directly (ie, by targeted microbubbles), which would
have enabled us to corroborate our positive US PFH-
loaded monocyte imaging findings in the TNF-a-
stimulated mice. We specifically chose not to avoid pos-
sible interference between US PFH-loaded monocyte
imaging and targeted microbubble measurements be-
cause a preceding measurement may influence adhesion
molecule availability or affinity for the subsequent mea-
surement. In future experiments, adhesion molecule
expression on the endothelium could be assessed by im-
munofluorescence imaging. With the use of 2-photon
laser-scanning microscopy, it should be (after staining
and fixation) possible to identify the endothelial/vascular
aspect in 3 dimensions in intact liver tissue and assess
the presence and density of adhesion molecules, such as
ICAM-1 and VCAM-1.31
Lastly, we did not assess liver tissue damage due to
administration of the PFH-loaded macrophage suspen-
sion. Dirven et al14 reported liver lesions on microbubble
administration, but only after 3 hours. Given that we
used PFH, which is fluid under the conditions consid-
ered,17 and that the US PFH-loaded monocyte imaging
procedure duration was limited (<15 minutes), we con-
sider damage due to PFH irrelevant in the present analy-
sis. At this stage, the longer-term effect of administering
monocytes/macrophages on the inflammatory process
in the liver remains of concern and deserves further
study, before sequential US PFH-loaded monocyte
imaging measurements can be considered tools for
studying progression/regression of NASH (in experi-
mental mice).2
As it stands, we have introduced and obtained proof
of concept for the much needed minimally invasive and
selective detection of inflammation in nonalcoholic fatty
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liver disease by US PFH-loaded monocyte imaging.2,9
Ultrasonic PFH-loaded monocyte imaging is able to
detect vascularly expressed inflammatory adhesion mole-
cules in the mouse liver on direct endothelial stimula-
tion. However, in our model for early developing
NASH, we did not detect inflammation by US PFH-
loaded monocyte imaging, which (apart from methodo-
logical limitations) may suggest that the time-dependent
relationship between parenchymal and endothelial
inflammation remains a fundamental issue to be
addressed.
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